indazoles has been researched along with Adenoma, Oxyphilic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Alemán, J; Mancha-Doblas, I; Molina-Vega, M; Sebastián-Ochoa, A; Tinahones-Madueño, F; Trigo-Pérez, JM | 1 |
| Foo, WC; George, DJ; Labriola, M; Zhang, T | 1 |
| Bible, KC; Burton, JK; Erlichman, C; Ivy, SP; Menefee, ME; Sideras, K | 1 |
3 other study(ies) available for indazoles and Adenoma, Oxyphilic
| Article | Year |
|---|---|
Tyrosine kinase inhibitors in iodine-refractory differentiated thyroid cancer: experience in clinical practice.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adult; Aged; Antineoplastic Agents; Axitinib; Carcinoma, Papillary; Disease-Free Survival; Female; Humans; Imidazoles; Indazoles; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Quinolines; Sorafenib; Survival Rate; Thyroid Neoplasms; Treatment Outcome | 2018 |
Pazopanib in the Treatment of Bilateral Multifocal Renal Oncocytomas: A Case Report.
Topics: Adenoma, Oxyphilic; Administration, Oral; Combined Modality Therapy; Humans; Indazoles; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Protein Kinase Inhibitors; Pyrimidines; Sulfonamides; Treatment Outcome | 2018 |
Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib.
Topics: Adenoma, Oxyphilic; Adult; Black or African American; Female; Hair; Humans; Hypopigmentation; Indazoles; Protein Kinase Inhibitors; Pyrimidines; Skin; Sulfonamides; Thyroid Neoplasms | 2010 |